Figure 1From: Assessment of organ dose reduction and secondary cancer risk associated with the use of proton beam therapy and intensity modulated radiation therapy in treatment of neuroblastomasRED corresponding with organ dose. The linear–exponential curves may have a plateau or a decline in RED at higher dose.Back to article page